Literature DB >> 32463457

PolyA-miner: accurate assessment of differential alternative poly-adenylation from 3'Seq data using vector projections and non-negative matrix factorization.

Hari Krishna Yalamanchili1,2, Callison E Alcott2,3,4, Ping Ji5, Eric J Wagner5, Huda Y Zoghbi1,2,6,7,8, Zhandong Liu2,7.   

Abstract

Almost 70% of human genes undergo alternative polyadenylation (APA) and generate mRNA transcripts with varying lengths, typically of the 3' untranslated regions (UTR). APA plays an important role in development and cellular differentiation, and its dysregulation can cause neuropsychiatric diseases and increase cancer severity. Increasing awareness of APA's role in human health and disease has propelled the development of several 3' sequencing (3'Seq) techniques that allow for precise identification of APA sites. However, despite the recent data explosion, there are no robust computational tools that are precisely designed to analyze 3'Seq data. Analytical approaches that have been used to analyze these data predominantly use proximal to distal usage. With about 50% of human genes having more than two APA isoforms, current methods fail to capture the entirety of APA changes and do not account for non-proximal to non-distal changes. Addressing these key challenges, this study demonstrates PolyA-miner, an algorithm to accurately detect and assess differential alternative polyadenylation specifically from 3'Seq data. Genes are abstracted as APA matrices, and differential APA usage is inferred using iterative consensus non-negative matrix factorization (NMF) based clustering. PolyA-miner accounts for all non-proximal to non-distal APA switches using vector projections and reflects precise gene-level 3'UTR changes. It can also effectively identify novel APA sites that are otherwise undetected when using reference-based approaches. Evaluation on multiple datasets-first-generation MicroArray Quality Control (MAQC) brain and Universal Human Reference (UHR) PolyA-seq data, recent glioblastoma cell line NUDT21 knockdown Poly(A)-ClickSeq (PAC-seq) data, and our own mouse hippocampal and human stem cell-derived neuron PAC-seq data-strongly supports the value and protocol-independent applicability of PolyA-miner. Strikingly, in the glioblastoma cell line data, PolyA-miner identified more than twice the number of genes with APA changes than initially reported. With the emerging importance of APA in human development and disease, PolyA-miner can significantly improve data analysis and help decode the underlying APA dynamics.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32463457      PMCID: PMC7337927          DOI: 10.1093/nar/gkaa398

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Metagenes and molecular pattern discovery using matrix factorization.

Authors:  Jean-Philippe Brunet; Pablo Tamayo; Todd R Golub; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

2.  Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development.

Authors:  Zhe Ji; Ju Youn Lee; Zhenhua Pan; Bingjun Jiang; Bin Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

3.  TAPAS: tool for alternative polyadenylation site analysis.

Authors:  Ashraful Arefeen; Juntao Liu; Xinshu Xiao; Tao Jiang
Journal:  Bioinformatics       Date:  2018-08-01       Impact factor: 6.937

4.  Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.

Authors:  Yuan Chu; Nathan Elrod; Chaojie Wang; Lei Li; Tao Chen; Andrew Routh; Zheng Xia; Wei Li; Eric J Wagner; Ping Ji
Journal:  Oncogene       Date:  2019-01-31       Impact factor: 9.867

Review 5.  Alternative polyadenylation and RNA-binding proteins.

Authors:  Ayse Elif Erson-Bensan
Journal:  J Mol Endocrinol       Date:  2016-05-20       Impact factor: 5.098

6.  Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling.

Authors:  Justin Brumbaugh; Bruno Di Stefano; Xiuye Wang; Marti Borkent; Elmira Forouzmand; Katie J Clowers; Fei Ji; Benjamin A Schwarz; Marian Kalocsay; Stephen J Elledge; Yue Chen; Ruslan I Sadreyev; Steven P Gygi; Guang Hu; Yongsheng Shi; Konrad Hochedlinger
Journal:  Cell       Date:  2017-12-14       Impact factor: 41.582

Review 7.  Alternative Polyadenylation: Another Foe in Cancer.

Authors:  Ayse Elif Erson-Bensan; Tolga Can
Journal:  Mol Cancer Res       Date:  2016-04-13       Impact factor: 5.852

8.  Detecting differential usage of exons from RNA-seq data.

Authors:  Simon Anders; Alejandro Reyes; Wolfgang Huber
Journal:  Genome Res       Date:  2012-06-21       Impact factor: 9.043

Review 9.  Alternative Polyadenylation: Methods, Findings, and Impacts.

Authors:  Wei Chen; Qi Jia; Yifan Song; Haihui Fu; Gang Wei; Ting Ni
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-10-12       Impact factor: 7.691

10.  QAPA: a new method for the systematic analysis of alternative polyadenylation from RNA-seq data.

Authors:  Kevin C H Ha; Benjamin J Blencowe; Quaid Morris
Journal:  Genome Biol       Date:  2018-03-28       Impact factor: 13.583

View more
  6 in total

1.  Cleavage stimulating factor 64 depletion mitigates cardiac fibrosis through alternative polyadenylation.

Authors:  Rahul Neupane; Keith Youker; Hari Krishna Yalamanchili; Katarzyna A Cieslik; Harry Karmouty-Quintana; Ashrith Guha; Rajarajan A Thandavarayan
Journal:  Biochem Biophys Res Commun       Date:  2022-01-29       Impact factor: 3.322

2.  Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma.

Authors:  Weimin Zhong; Yulong Wu; Maoshu Zhu; Hongbin Zhong; Chaoqun Huang; Yao Lin; Jiyi Huang
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-19       Impact factor: 8.886

3.  A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma.

Authors:  Rongkang Li; Chong Lu; Xinji Li; Xuan Chen; Guocheng Huang; Zhenyu Wen; Hang Li; Lingzhi Tao; Yimin Hu; Zhengping Zhao; Zebo Chen; Yongqing Lai
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

4.  Zika Virus Infection Alters Gene Expression and Poly-Adenylation Patterns in Placental Cells.

Authors:  Stephanea L Sotcheff; John Yun-Chung Chen; Nathan Elrod; Jun Cao; Elizabeth Jaworski; Mugé N Kuyumcu-Martinez; Pei-Yong Shi; Andrew L Routh
Journal:  Pathogens       Date:  2022-08-18

5.  Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research.

Authors:  Liusheng Wu; Yanfeng Zhong; Xiaoya Yu; Dingwang Wu; Pengcheng Xu; Le Lv; Xin Ruan; Qi Liu; Yu Feng; Jixian Liu; Xiaoqiang Li
Journal:  Anticancer Drugs       Date:  2022-08-09       Impact factor: 2.389

Review 6.  The Detection and Bioinformatic Analysis of Alternative 3' UTR Isoforms as Potential Cancer Biomarkers.

Authors:  Nitika Kandhari; Calvin A Kraupner-Taylor; Paul F Harrison; David R Powell; Traude H Beilharz
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.